---
category: news
title: "The Nation's #1 Mortgage Broker announces a new corporate logo designed to strengthen their image and position themselves as a FinTech company"
excerpt: "Loan Factory, the nation's #1 mortgage broker is proud to announce a new logo that reflects their ongoing efforts to make the loan process faster, simpler, and more customer-friendly. This includes the development of an AI-powered loan processing system that will definitely reshape the US home mortgage industry."
publishedDateTime: 2022-04-20T05:16:00Z
originalUrl: "https://www.finanzen.at/nachrichten/aktien/the-nations-1-mortgage-broker-announces-a-new-corporate-logo-designed-to-strengthen-their-image-and-position-themselves-as-a-fintech-company-1031361404"
webUrl: "https://www.finanzen.at/nachrichten/aktien/the-nations-1-mortgage-broker-announces-a-new-corporate-logo-designed-to-strengthen-their-image-and-position-themselves-as-a-fintech-company-1031361404"
ampWebUrl: "https://www.finanzen.at/nachrichten/amp/the-nations-1-mortgage-broker-announces-a-new-corporate-logo-designed-to-strengthen-their-image-and-position-themselves-as-a-fintech-company-1031361404"
cdnAmpWebUrl: "https://www-finanzen-at.cdn.ampproject.org/c/s/www.finanzen.at/nachrichten/amp/the-nations-1-mortgage-broker-announces-a-new-corporate-logo-designed-to-strengthen-their-image-and-position-themselves-as-a-fintech-company-1031361404"
type: article
quality: 0
heat: -1
published: false

provider:
  name: finanzen
  domain: finanzen.at

topics:
  - AI in Finance
  - AI

related:
  - title: "Shionogi and NEC enter into strategic research collaboration for novel hepatitis B therapeutic vaccine"
    excerpt: "Shionogi and NEC announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. NEC OncoImmunity, an NEC subsidiary that specializes in artificial intelligence-driven biotechnology,"
    publishedDateTime: 2022-04-19T07:36:00Z
    webUrl: "https://www.poandpo.com/companies/shionogi-and-nec-enter-into-strategic-research-collaboration-for-novel-hepatitis-b-therapeutic-vaccine/"
    ampWebUrl: "https://www.poandpo.com/companies/shionogi-and-nec-enter-into-strategic-research-collaboration-for-novel-hepatitis-b-therapeutic-vaccine.amp"
    cdnAmpWebUrl: "https://www-poandpo-com.cdn.ampproject.org/c/s/www.poandpo.com/companies/shionogi-and-nec-enter-into-strategic-research-collaboration-for-novel-hepatitis-b-therapeutic-vaccine.amp"
    type: article
    provider:
      name: poandpo.com
      domain: poandpo.com
    quality: 28
    images:
      - url: "https://res.cloudinary.com/scotfiles/image/fetch/https://www.histerius.com/hs0422/shionogi.jpg"
        width: 1200
        height: 675
        isCached: true
  - title: "Shionogi and NEC Enter into Strategic Research Collaboration for Novel Hepatitis B Therapeutic Vaccine"
    excerpt: "Shionogi& Co., Ltd. and NEC Corporation, today announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. NEC OncoImmunity,"
    publishedDateTime: 2022-04-18T06:03:00Z
    webUrl: "https://www.nasdaq.com/press-release/shionogi-and-nec-enter-into-strategic-research-collaboration-for-novel-hepatitis-b"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 18
  - title: "Shionogi, NEC collaborate on research for novel hepatitis B therapeutic vaccine"
    excerpt: "Shionogi & Co Ltd and NEC Corp have announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine. NEC OncoImmunity, an NEC subsidiary that specializes in artificial intelligence-driven biotechnology,"
    publishedDateTime: 2022-04-19T21:48:00Z
    webUrl: "https://japantoday.com/category/tech/shionogi-nec-collaborate-on-research-for-novel-hepatitis-b-therapeutic-vaccine"
    type: article
    provider:
      name: Japan Today
      domain: japantoday.com
    quality: 0

secured: "oXFpzTt7AdQuROycjP33P5RWkEJJNiXIbG8zJmh9d+W6IMnKvlUJQWFrD802/tlFZEn+WJsG+mbesO/S1IS2Ff03fcPNg8dscHOB1kXwolerjVEl6bk9ULY1wfzpwimqjcWP6CvsDgcSLl+1Gn9cAkAM0c2+wu0vHyG1TeAvdpKj7m5tuYFyKtossJo47q+IYrz5s3S4TurkaCLtI/pxtehc7sYcnpMFlJKcN7Dftw40C7RsXPOnADkCSlpDa0CASmPi7hgvB76EzwDlMZ5MlxO+WZc9lqb58oM/fq1J2iKFEi3pFZVFxX8wghnulj1WniOmt/CvLrC/Kai8yRtgjXtf54mV2ZhRRf6AyN1KMoM=;/K/0BdjpW8IaXJ1wttKD4Q=="
---

